Literature DB >> 11833865

Factors related to the occurrence of isolated sleep paralysis elicited during a multi-phasic sleep-wake schedule.

Tomoka Takeuchi1, Kazuhiko Fukuda, Yuka Sasaki, Maki Inugami, Timothy I Murphy.   

Abstract

STUDY
OBJECTIVES: To further investigate mechanisms of isolated sleep paralysis (ISP) in normal individuals, we experimentally elicited ISPs by facilitating sleep onset REM periods (SOREMP), a prerequisite of ISPs, and examined behavioral and psychological measurements relating to ISP appearances.
DESIGN: The multi-phasic sleep/wake schedule (MPS) began at approximately midnight and ended when net sleep reached 7.5 hours. Participants were awakened after every 5 min of REM sleep to obtain a maximum number of SOREMPs. Upon each awakening, mentation reports and subjective measurements were collected. Performance tests were then assigned.
SETTING: Sleep lab, Tokyo Metropolitan Institute for Neurosciences, Japan. PARTICIPANTS: Thirteen healthy Japanese students (10 males) with high self-reported frequencies of ISPs but no other narcolepsy-related symptoms. MEASUREMENTS AND
RESULTS: From 184 sleep interruptions, 8 ISP episodes were obtained. In within participant comparisons between episodes with and without ISPs, the vigilance task (VT) reaction times were elevated before SOREMPs with ISPs. In between analyses (ISP vs non-ISP), the ISP group showed poorer performance, more complaints of physical, mental, and neurotic symptoms, increased subjective fatigue and increased stage 1 throughout the entire schedule. VT hit rates remained constant in the non-ISP group, but dropped in the later part of schedule in the ISP group. Subjective sleepiness dropped over time in the non-ISP group while it slightly increased in the ISP group.
CONCLUSIONS: ISP is likely to appear as a phenotype of REM dissociation during SOREMP when participants with low tolerance for disrupted sleep-wake rhythms are placed in this type of schedule.

Entities:  

Mesh:

Year:  2002        PMID: 11833865     DOI: 10.1093/sleep/25.1.89

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  8 in total

Review 1.  Awakening Ptosis: A Clinical Review.

Authors:  Abidemi Idowu Otaiku
Journal:  Neuroophthalmology       Date:  2018-06-13

2.  Risk factors of sleep paralysis in a population of Polish students.

Authors:  Paulina Wróbel-Knybel; Michał Flis; Joanna Rog; Baland Jalal; Hanna Karakuła-Juchnowicz
Journal:  BMC Psychiatry       Date:  2022-06-07       Impact factor: 4.144

3.  A case of sleep paralysis with hypnopompic hallucinations. Recurrent isolated sleep paralysis associated with hypnopompic hallucinations, precipitated by behaviorally induced insufficient sleep syndrome.

Authors:  David E McCarty; Andrew L Chesson
Journal:  J Clin Sleep Med       Date:  2009-02-15       Impact factor: 4.062

4.  Are sleep paralysis and false awakenings different from REM sleep and from lucid REM sleep? A spectral EEG analysis.

Authors:  Greta Mainieri; Jean-Baptiste Maranci; Pierre Champetier; Smaranda Leu-Semenescu; Ana Gales; Pauline Dodet; Isabelle Arnulf
Journal:  J Clin Sleep Med       Date:  2021-04-01       Impact factor: 4.062

5.  A twin and molecular genetics study of sleep paralysis and associated factors.

Authors:  Dan Denis; Christopher C French; Richard Rowe; Helena M S Zavos; Patrick M Nolan; Michael J Parsons; Alice M Gregory
Journal:  J Sleep Res       Date:  2015-02-09       Impact factor: 3.981

Review 6.  A clinician's guide to recurrent isolated sleep paralysis.

Authors:  Brian A Sharpless
Journal:  Neuropsychiatr Dis Treat       Date:  2016-07-19       Impact factor: 2.570

Review 7.  Relationships between sleep paralysis and sleep quality: current insights.

Authors:  Dan Denis
Journal:  Nat Sci Sleep       Date:  2018-11-02

8.  Terror and bliss? Commonalities and distinctions between sleep paralysis, lucid dreaming, and their associations with waking life experiences.

Authors:  Dan Denis; Giulia L Poerio
Journal:  J Sleep Res       Date:  2016-07-27       Impact factor: 3.981

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.